Skip to main content
. 2023 Oct 11;12:90. doi: 10.1186/s40164-023-00454-7

Fig. 1.

Fig. 1

CD22 and CD22 CAR structure. A CD22 molecule and the recognized domain of different CD22 scFv and ADCs. B CD22 CAR structures in preclinical and clinical use. ITIM immunoreceptor tyrosine-based inhibitory motif. The image was created using BioRender (Biorender, Toronto, ON, Canada)